Partnering in the Global Generics Industry 2010: A guide to companies

Date: October 1, 2010
Pages: 472
Price:
US$ 1,040.00
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P39C906E2B9EN
Leaflet:

Download PDF Leaflet

Partnering in the Global Generics Industry 2010: A guide to companies
Facts, statistics and insights on 168 medium-sized generic manufacturers from 40 countries

The operating environment for generics companies is changing rapidly as the industry matures and growth focuses on new market opportunities.

The current economic downturn has impacted the sector in terms of the number and types of deal but consolidation continues to affect the market, with a smaller number of big players dominating.

Acquisition is still a favoured route to fast market access but strategic partnering is on the rise. In such a market you need to know...

But...
  • Who are the medium-sized companies of note?
  • How well do they perform?
  • What drugs do they produce?
  • Where are they located?
Identify merger, acquisition and partner candidates in the rapidly changing global generics market…

Consolidation and collaboration runs throughout the generic industry. Here's just a taste of the acquisitions, controlling investments and deals reported recently...
  • URL Pharma acquire manufacturing assets of PharmPro
  • Luitpold Pharma acquires Pharmaforce
  • Hi-Tech Pharmacal acquires product line from Blaine Company
  • Aspen Pharmacare acquires Sigma’s pharmaceutical division
  • Sun Pharmaceuticals’ long expected acquisition of Taro Pharmaceuticals
  • Sandoz acquires Ebewe Pharmaceuticals
  • GSK acquires Stiefel
  • Strides Arcolab acquires Ascent Pharmahealth
  • sanofi-aventis form Japanese joint venture with Nichi-Iko
  • Adcock-Ingram acquires Ghanaian manufacturer Ayrton
  • Cephalon acquires Mepha
Strategic partnering

In addition to outright purchase, strategic partnering or the acquisition of specific drug assets is on the rise as companies seek to bring lower costs and focus to their portfolios. With business cycles growing shorter and shorter, market entry is quicker, more reliable and less risky through acquisition and partnering.

The fundamental market drivers are sound

In addition to ongoing expansion, there are other drivers which are causing the generic companies to consider the future:
  • Over the next 5 years a number of blockbuster pharmaceutical products such as Lipitor, Cozaar, Lovenox, Plavix, Cymbalta and Seroquel will be losing patent protection.
  • The number of biologics coming into the remit of generic companies is increasing, raising interest in companies with biosimilars production capability.
The branded industry’s response

The branded industry continues to vigorously protect its IP and maximise the lifetime value of its products. While legal initiatives will remain a key weapon there will also be commercial responses such as issuing early branded generics, collaborative working with a limited number of generic producers, new formulations or combination products.

Identify new business opportunities and assess risk

For everyone needing to evaluate the generic industry’s competitive landscape, this thoroughly-researched and expanded 3rd Edition of Partnering in the Global Generics Industry 2010: A guide to companies (published October 2010) is essential reading. In 450 information-packed pages this completely revised edition references 168 generics companies operating in 40 markets around the world.

Africa/Middle East
  • EIPICo Egypt
  • Dexcel Pharma Israel
  • Taro Pharmaceutical Industries Israel
  • Hikma Jordan
  • Regal Pharmaceuticals Kenya
  • Tabuk Pharmaceutical Manufacturing Saudi Arabia
  • Adcock Ingram South Africa
  • Cipla Medpro South Africa
Asia/Pacific
  • Ascent Pharmahealth Australia
  • Australian Pharmaceutical Industries Australia
  • Hamilton Laboratories Australia
  • Sigma Pharmaceuticals Australia
  • Beximco Pharmaceuticals Bangladesh
  • China Pharma Holdings China
  • Alembic India
  • Alkem Laboratories India
  • Biocon India
  • Emcure Pharmaceuticals India
  • Gland Pharma India
  • Glenmark Pharmaceuticals India
  • Hetero Drugs India
  • Indoco Remedies India
  • JB Chemicals & Pharmaceuticals India
  • Jubilant Organosys India
  • Natco Pharma India
  • Orchid Chemicals & Pharmaceuticals India
  • Strides Arcolab India
  • Torrent Pharmaceuticals India
  • USV India
  • Kimia Indonesia
  • Nichi-iko Pharmaceutical Japan
  • Towa Pharmaceutical Japan
  • CCM Pharmaceuticals Malaysia
  • Inno Biologics Malaysia
  • CCL Pakistan
  • Dr Raza Pharma Pakistan
  • Epla Labs Pakistan
  • Highnoon Laboratories Pakistan
  • Abdi Ibrahim Turkey
  • Bilim Pharmaceuticals Turkey
  • EastPharma Turkey
  • Mustafa Nevzat Pharmaceuticals Turkey
Europe
  • Ebewe Pharma Austria
  • Sopharma Bulgaria
  • Unipharm Bulgaria
  • Belupo Croatia
  • Alternova Denmark
  • Orifarm Denmark
  • Biogaran France
  • Consilient Health Ireland
  • Reliance GeneMedix Ireland
  • Eurand Italy
  • Grindeks Latvia
  • Sanitas Lithuania
  • Hovione FarmaCiencia Portugal
  • Antibiotice Romania
  • Europharm Romania
  • Akrikhin Russia
  • Bryntsalov Russia
  • Erka Farm Russia
  • Farmacon Russia
  • Pharmstandard Russia
  • Veropharm Russia
  • Biotika Slovakia
  • Combino Pharm Spain
  • Invent Farma Group Spain
  • Laboratorios Cinfa Spain
  • Acino Pharma Switzerland
  • Azad Switzerland
  • Helvepharm Switzerland
  • Mepha Pharma Switzerland
  • Spirig Switzerland
  • Streuli Switzerland
  • Goldshield Group UK
  • Kent Pharmaceuticals UK
  • ProStrakan UK
  • Rosemont Pharmaceutical UK
North America
  • Labopharm Canada
  • Pharmascience Canada
  • Akorn USA
  • Alovgen USA
  • Amneal Pharmaceuticals USA
  • Amphastar Pharmaceuticals USA
  • Anchen Pharmaceuticals USA
  • APP Pharmaceuticals USA
  • Banner Pharmacaps USA
  • Bedford Laboratories USA
  • Bio-Nucleonics USA
  • Boca Pharmacal USA
  • Breckenridge Pharma USA
  • Caraco Pharmaceutical Laboratories USA
  • Carolina Medical Products Company USA
  • Cedar Pharmaceuticals USA
  • Cephazone Pharma USA
  • CorePharma USA
  • Cypress Pharmaceutical USA
  • Ferndale Laboratories USA
  • Fleming Pharmaceuticals USA
  • Fougera USA
  • G&W Laboratories USA
  • GeneraMedix USA
  • Hanford Manufacturing USA
  • Harmony Labs USA
  • Heritage Pharmaceuticals USA
  • Hi-Tech Pharmacal USA
  • Indicus Pharmaceuticals USA
  • InvaGen Pharmaceuticals USA
  • Kremers-Urban (KUDCo) USA
  • KV Pharmaceutical USA
  • KVK-Tech USA
  • Luitpold Pharmaceuticals USA
  • Lyne Laboratories USA
  • Mallinckrodt USA
  • Mikart USA
  • Neil Laboratories USA
  • Nephron Pharmaceuticals USA
  • Paddock Laboratories USA
  • Pharmaceutical Associates USA
  • PharmaForce USA
  • Prasco USA
  • Prometheus Laboratories USA
  • Roxane Laboratories USA
  • RxElite Holdings USA
  • Silarx Pharmaceuticals USA
  • Spear Pharmaceuticals USA
  • Stasun Pharmaceuticals USA
  • Stiefel USA
  • SuperGen USA
  • ThePharmaNetwork USA
  • Three Rivers Pharmaceuticals USA
  • Tris Pharma USA
  • URL Pharma USA
  • Upsher-Smith Laboratories USA
  • VersaPharm USA
  • Vista Pharmaceuticals USA
  • VistaPharm USA
  • X-GEN Pharmaceuticals USA
South America
  • Osmotica Pharmaceutical Argentina
  • Ache Brazil
  • Americano Brazil
  • Biolab Brazil
  • Cimed Brazil
  • Cristalia Brazil
  • EMS-Sigma Brazil
  • Eurofarma Brazil
  • LAFEPE Brazil
  • Libbs Farmaceutica Brazil
  • Medley Brazil
  • Prati-Donaduzzi Brazil
  • Andromaco Chile
  • Bestpharma Chile
  • Biosano Chile
  • Maver Chile
  • Mintlab Chile
  • Ecar Colombia
  • Genfar Colombia
  • La Sante Colombia
  • Lafrancol Colombia
  • Laboratorios Kendrick Mexico
  • Laboratorios Silanes Mexico
  • Farmindustria Peru
  • Induquimica Peru
  • Infarmasa Peru
  • Calox Internacional Venezuela
  • Cofasa Venezuela
  • Kimiceg Venezuela
  • Leti Venezuela
  • Meyer Venezuela
INTRODUCTION

Companies in this report

ARGENTINA

Osmotica Pharmaceutical
Background
Products
Contact Details

AUSTRALIA

Ascent Pharmahealth
Background
Products
Financials
Major Developments
Contact Details

Australian Pharmaceutical Industries
Background
Financials
Major Developments
Contact Details

Hamilton Laboratories
Background
Products
Contact Details

Sigma Pharmaceuticals
Background
Products
Financials
Major Developments
Contact Details

AUSTRIA

Ebewe Pharma
Background
Products
Financials
Major Developments
Contact Details

Bangladesh
Beximco Pharmaceuticals
Background
Products
Financials
Major Developments
Contact Details

BRAZIL

Ache
Background
Products
Financials
Major Developments
Contact Details

Americano
Background
Products
Financials
Contact Details

Biolab
Background
Products
Financials
Contact Details

Cimed
Background
Products
Financials
Contact Details

Cristalia
Background
Products
Financials
Contact Details

EMS-Sigma
Background
Products
Financials
Contact Details

Eurofarma
Background
Major Developments
Contact Details

LAFEPE
Background
Products
Contact Details

Libbs Farmaceutica
Background
Products
Financials
Major Developments
Contact Details

Medley
Background
Products
Financials
Major Developments
Contact Details

Prati-Donaduzzi
Background
Products
Financials
Contact Details

BULGARIA

Sopharma
Background
Products
Financials
Contact Details

Unipharm
Background
Contact Details

CANADA

Labopharm
Background
Products
Financials
Major Developments
Contact Details

Pharmascience
Background
Products
Major Developments
Contact Details

CHILE

Andromaco
Background
Products
Financials
Major Developments
Contact Details

Bestpharma
Background
Products
Contact Details

Biosano
Background
Products
Financials
Contact Details

Maver
Background
Contact Details

Mintlab
Background
Contact Details

CHINA

China Pharma Holdings
Background
Products
Financials
Contact Details

COLOMBIA

Ecar
Background
Contact details

Genfar
Background
Contact Details

La Sante
Background
Contact Details

Lafrancol
Background
Contact Details

CROATIA

Belupo
Background
Products
Contact Details

DENMARK

Alternova
Background
Products
Contact Details

Orifarm
Background
Products
Contact Details

EGYPT

EIPICo
Background
Products
Contact Details

FRANCE

Biogaran
Background
Contact Details

INDIA

Alembic
Background
Products
Financials
Major Developments
Contact Details

Alkem Laboratories
Background
Products
Major Developments
Contact Details

Biocon
Background
Products
Financials
Major Developments
Contact Details

Emcure Pharmaceuticals
Background
Products
Major Developments
Contact Details

Gland Pharma
Background
Products
Contact Details

Glenmark Pharmaceuticals
Background
Products
Financials
Major Developments
Contact Details

Hetero Drugs
Background
Products
Major Developments
Contact Details

Indoco Remedies
Background
Products
Financials
Major Developments
Contact Details

JB Chemicals & Pharmaceuticals
Background
Products
Financials
Major Developments
Mergers, Acquisitions and Agreements
Contact Details

Jubilant Organosys
Background
Products
Financials
Major Developments
Contact Details

Natco Pharma
Background
Products
Financials
Major Developments
Contact Details

Orchid Chemicals & Pharmaceuticals
Background
Products
Financials
Major Developments
Contact Details

Strides Arcolab
Background
Products
Financials
Major Developments
Contact Details

Torrent Pharmaceuticals
Background
Products
Financials
Major Developments
Contact Details

USV
Background
Products
Contact Details

INDONESIA

Kimia
Background
Contact Details

Ireland
Consilient Health
Background
Products
Contact Details

Reliance GeneMedix
Background
Products
Financials
Major Developments
Contact Details

Israel
Dexcel Pharma
Background
Products
Major Developments
Contact Details

Taro Pharmaceutical Industries
Background
Products
Financials
Major Developments
Contact Details

ITALY

Eurand
Background
Products
Financials
Major Developments
Contact Details

JAPAN

Nichi-iko Pharmaceutical
Background
Financials
Major Developments
Contact Details

Towa Pharmaceutical
Background
Products
Financials
Major developments
Contact Details

JORDAN

Hikma
Background
Products
Financials
Major Developments
Contact Details

KENYA

Regal Pharmaceuticals
Background
Products
Major Developments
Contact Details

LATVIA

Grindeks
Background
Products
Financials
Major Developments
Contact Details

LITHUANIA

Sanitas
Background
Products
Financials
Major Developments
Contact Details

MALAYSIA

CCM Pharmaceuticals
Background
Products
Financials
Major Developments
Contact Details

Inno Biologics
Background
Products
Contact Details

MEXICO

Laboratorios Kendrick
Background
Contact Details

Laboratorios Silanes
Background
Contact Details

PAKISTAN

CCL
Background
Contact Details
Dr Raza Pharma
Background
Contact Details

Epla Labs
Background
Products
Contact Details

Highnoon Laboratories
Background
Products
Financials
Contact Details

PERU

Farmindustria
Background
Contact Details

Induquimica
Background
Products
Contact Details

Infarmasa
Background
Financials
Contact Details

PORTUGAL

Hovione FarmaCiencia
Background
Products
Financials
Major Developments
Contact Details

ROMANIA

Antibiotice
Background
Products
Financials
Contact Details

Europharm
Background
Contact Details

RUSSIA

Akrikhin
Background
Products
Financials
Contact Details

Bryntsalov A
Background
Contact Details

Erka Farm
Background
Farmacon
Background
Contact Details

Pharmstandard
Background
Products
Financials
Major Developments
Contact Details

Veropharm
Background
Financials
Contact Details

SAUDI ARABIA

Tabuk Pharmaceutical Manufacturing
Background
Contact Details

SLOVAKIA

Biotika
Background
Financials
Contact Details

SOUTH AFRICA

Adcock Ingram
Background
Products
Financials
Major Developments
Contact Details

Cipla Medpro
Background
Products
Financials
Major Developments
Contact Details

SPAIN

Combino Pharm
Background
Products
Major Developments
Contact Details

Invent Farma Group
Background
Products
Major Developments
Contact Details

Laboratorios Cinfa
Background
Products
Financials
Major Developments
Contact Details

SWITZERLAND

Acino Pharma
Background
Products
Financials
Major Developments
Contact Details

Azad
Background
Products
Major Developments
Contact Details

Helvepharm
Background
Contact Details

Mepha Pharma
Background
Financials
Contact Details

Spirig
Background
Products
Financials
Contact Details

Streuli
Background
Contact Details

TURKEY

Abdi Ibrahim
Background
Products
Major Developments
Contact Details

Bilim Pharmaceuticals
Background
Products
Contact Details

EastPharma
Background
Products
Financials
Contact Details

Mustafa Nevzat Pharmaceuticals
Background
Products
Major Developments
Contact Details

UK

Goldshield Group
Background
Products
Financials
Major Developments
Contact Details

Kent Pharmaceuticals
Background
Financials
Major Developments
Contact Details

ProStrakan
Background
Products
Financials
Major Developments
Contact Details

Rosemont Pharmaceutical
Background
Products
Financials
Major Developments
Contact Details

USA

Akorn
Background
Products
Financials
Major Developments
Contact Details

Alovgen
Background
Products
Major Developments
Contact Details

Amneal Pharmaceuticals
Background
Products
Major Developments
Contact Details

Amphastar Pharmaceuticals
Background
Products
Major Developments
Contact Details

Anchen Pharmaceuticals
Background
Products
Major Developments
Contact Details

APP Pharmaceuticals
Background
Products
Major Developments
Contact Details

Banner Pharmacaps
Background
Products
Major Developments
Contact Details

Bedford Laboratories
Background
Products
Major Developments
Contact Details

Bio-Nucleonics
Background
Products
Contact Details

Boca Pharmacal
Background
Products
Contact Details

Breckenridge Pharma
Background
Products
Major Developments
Contact Details

Caraco Pharmaceutical Laboratories
Background
Products
Financials
Major Developments
Contact Details

Carolina Medical Products Company
Background
Products
Contact Details

Cedar Pharmaceuticals
Background
Products
Contact Details

Cephazone Pharma
Background
Products
Contact Details

CorePharma
Background
Products
Major Developments
Contact Details

Cypress Pharmaceutical
Background
Products
Major Developments
Contact Details

Ferndale Laboratories
Background
Products
Major Developments
Contact Details

Fleming Pharmaceuticals
Background
Products
Contact Details

Fougera
Background
Products
Major Developments
Contact Details

G&W Laboratories
Background
Products
Contact Details

GeneraMedix
Background
Products
Major Developments
Contact Details

Hanford Manufacturing
Background
Products
Major Developments
Contact Details

Harmony Labs
Background
Products
Contact Details

Heritage Pharmaceuticals
Background
Products
Major Developments
Contact Details

Hi-Tech Pharmacal
Background
Products
Financials
Major Developments
Contact Details

Indicus Pharmaceuticals
Background
Products
Contact Details

InvaGen Pharmaceuticals
Background
Products
Major Developments
Contact Details

Kremers-Urban (KUDCo)
Background
Products
Major Developments
Contact Details

KV Pharmaceutical
Background
Products
Financials
Major Developments
Contact Details

KVK-Tech
Background
Products
Contact Details

Luitpold Pharmaceuticals
Background
Products
Major Developments
Contact Details

Lyne Laboratories
Background
Products
Contact Details

Mallinckrodt
Background
Products
Major Developments
Contact Details

Mikart
Background
Products
Contact Details

Neil Laboratories
Background
Products
Contact Details

Nephron Pharmaceuticals
Background
Products
Contact Details

Paddock Laboratories
Background
Products
Major Developments
Contact Details

Pharmaceutical Associates
Background
Products
Contact Details

PharmaForce
Background
Products
Major Developments
Contact Details

Prasco
Background
Products
Major Developments
Contact Details

Prometheus Laboratories
Background
Products
Contact Details

Roxane Laboratories
Background
Products
Major Developments
Contact Details

RxElite Holdings
Background
Products
Major Developments
Contact Details

Silarx Pharmaceuticals
Background
Products
Contact Details

Spear Pharmaceuticals
Background
Products
Contact Details

Stason Pharmaceuticals
Background
Products
Major Developments
Contact Details

Stiefel
Background
Products
Major Developments
Contact Details

SuperGen
Background
Products
Financials
Major Developments
Contact Details

ThePharmaNetwork
Background
Products
Contact Details

Three Rivers Pharmaceuticals
Background
Products
Major Developments
Contact Details

Tris Pharma
Background
Major Developments
Contact Details

URL Pharma
Background
Products
Major Developments
Contact Details

Upsher-Smith Laboratories
Background
Products
Major Developments
Contact Details

VersaPharm
Background
Products
Contact Details

Vista Pharmaceuticals
Background
Products
Contact Details

VistaPharm
Background
Products
Contact Details

X-GEN Pharmaceuticals
Background
Products
Major Developments
Contact Details

Venezuela
Calox Internacional
Background
Contact Details

Cofasa
Background
Contact Details

Kimiceg
Background
Contact Details

Leti
Background
Contact Details

Meyer
Background
Contact Details

INDEX OF TABLES

Companies in the report by country of origin
Osmotica Pharmaceutical ANDA Approvals, 2002 – June 2010
Ascent Pharmahealth: consolidated fiscal year results in A$000s
Australian Pharmaceutical Industries: consolidated fiscal year results in A$000s
Sigma Pharmaceuticals: fiscal year results in A$ millions
Ebewe Pharma ANDA Approvals, 2002-09
Beximco Pharmaceuticals: fiscal year results, in BDT000s
Cimed: Sales, 2004 – 2007
LAFEPE: Product Lines
Libbs Farmaceutica: Pharmaceutical Sales, 2000 – 2006
Medley: International Agreements, 1992 – 2005
Medley: pharmacy sales by value in US$ millions
Medley: generic sales by volume
Sopharma: Financial Data, in Leva 000s
Labopharm: fiscal year results, in C$000s
Andromaco: Financial Results, 2000 – 2007
Biosano: Product Portfolio
Alembic: manufacturing facilities
Alembic ANDA Approvals, 2002 – June 2010
Alembic: Financial Results, in Rs millions
Alkem Laboratories ANDA Approvals, 2002 – June 2010
Biocon: Consolidated Financial Results, in Rs millions
Emcure Pharmaceuticals ANDA Approvals, 2002 – June 2010
Gland Pharma ANDA Approvals, 2002 – June 2010
Glenmark Pharmaceuticals / Glenmark Generics ANDA Approvals, January 2002 – June 2010
Glenmark Pharmaceuticals: consolidated financial results in Rs millions
Glenmark Pharmaceuticals: consolidated financial results by business in Rs millions
Hetero Drugs ANDA Approvals, 2002 – June 2010
Indoco Remedies: Financial Results (Rs millions)
Indoco Remedies: Financial Results (US$ millions)
Unique Pharmaceutical Laboratories ANDA Approvals, 2002 – June 2010
JB Chemicals & Pharmaceuticals: Financial Results, in Rs millions
JB Chemicals & Pharmaceuticals: Financial Results, in US$ millions
Trigen Laboratories / Cadista Pharmaceuticals / Jubilant Pharmaceuticals ANDA Approvals, January 2002 – June 2010
Jubilant Organosys: standalone financial results, in Rs millions
Natco Pharma ANDA Approvals, January 2002 – June 2010
Natco Pharma: standalone financial results in Rs millions
Orchid Healthcare ANDA Approvals, January 2002 – June 2010
Orchid Chemicals & Pharmaceuticals: fiscal year results in Rs millions
Strides Arcolab ANDA Approvals, January 2002 – June 2010
Akorn-Strides ANDA Approvals, January 2002 – June 2010
Sagent-Strides ANDA Approvals, January 2002 – June 2010
Strides Arcolab: consolidated fiscal year results in Rs millions
Torrent Pharmaceuticals ANDA Approvals, January 2002 – June 2010
Torrent Pharmaceuticals: consolidated financial results, in Rs millions
Reliance GeneMedix: financial results, in euro 000s
Dexcel ANDA Approvals, January 2002 – June 2010
Taro Pharmaceutical Industries ANDA Approvals, January 2002 – June 2010
Taro Pharmaceutical Industries: financial results, in US$000s
Taro Pharmaceutical Industries: sales by location, in US$000s
Taro Pharmaceutical Industries: preliminary financial results, in US$000s
Eurand ANDA Approvals, January 2002 – June 2010
Eurand: consolidated financial results, in euro 000s
Nichi-Iko: Medium Term Business Plan Goals (¥ millions)
Towa Pharmaceutical: Fiscal Year Sales, in yen millions
Hikma Pharmaceuticals ANDA Approvals, January 2002 – June 2010
West-Ward ANDA Approvals, January 2002 – June 2010
Hikma: financial results, in US$000s
Hikma: financial results by region, in US$000s
Grindeks Group: financial results, in LVL000s
Grindeks Group: sales by location, in LVL000s
Sanitas: Group Financial Results, in LTL000s
Sanitas: Selected Financial Results by Region, in LTL000s
CCM: Group Financial Results, in RM000s
Antibiotice: Financial Results, 2002 – 2007
Pharmstandard: production by facility, 2008
Pharmstandard: financial results, 2004 – 2008 (R millions)
Pharmstandard: pharmaceutical sales, 2007 – 2008
Pharmstandard: top 10 OTCs, 2007 – 2008
Adcock Ingram: Fiscal Year Results, in R000s
Cipla Medpro: Group Financial Results (R000s)
EastPharma: Consolidated Financial Results, in US$000s
Goldshield: Financial Results, 2003 – 2009 (£000s)
Goldshield: Sales by Region, 2006 – 2009 (£000s)
Goldshield: Selected Sales by Segment, 2006 – 2009 (£000s)
ProStrakan: Consolidated Financial Results, in £ millions
ProStrakan: Selected Consolidated Financial Results by Destination, in £ millions
Akorn ANDA Approvals, 2002 – June 2010
Akorn-Strides ANDA Approvals, 2002 – June 2010
Akorn: Financial Results in US$000s
Amneal Pharmaceuticals ANDA Approvals, 2006 – June 2010
Interpharm ANDA Approvals, 2002 – 2008
Amphastar Pharmaceuticals ANDA Approvals, 2002 – June 2010
International Medication Systems ANDA Approvals, 2002 – June 2010
Anchen Pharmaceuticals ANDA Approvals, 2002 – June 2010
American Pharmaceutical Partners ANDA Approvals, 2002 – 2006
Abraxis ANDA Approvals, 2006 – 2008
APP Pharmaceuticals ANDA Approvals, 2008 – June 2010
Banner Pharmacaps ANDA Approvals, 2002 – June 2010
Bedford Laboratories ANDA Approvals, 2002 – June 2010
Ben Venue Laboratories ANDA Approvals, 2002 – June 2010
Bio-Nucleonics ANDA Approvals, 2002 – June 2010
Boca Pharmacal ANDA Approvals, 2002 – June 2010
Breckenridge Pharmaceutical ANDA Approvals, 2002 – June 2010
Caraco Pharmaceutical Laboratories ANDA Approvals, 2002 – June 2010
Caraco Pharmaceutical Laboratories: Financial Results, FY2005 – FY2009 (US$000s)
Carolina Medical Products ANDA Approvals, 2002 – June 2010
Cedar Pharmaceuticals ANDA Approvals, 2002 – June 2010
Cephazone Pharma ANDA Approvals, 2002 – June 2010
CorePharma ANDA Approvals, 2002 – June 2010
Cypress Pharmaceutical ANDA Approvals, 2002 – June 2010
Ferndale Laboratories ANDA Approvals, 2002 – June 2010
Fleming & Company Pharmaceuticals ANDA Approvals, 2002 – June 2010
Altana ANDA Approvals, 2002 – June 2010
Nycomed ANDA Approvals, 2002 – June 2010
G&W Laboratories ANDA Approvals, 2002 – June 2010
GeneraMedix ANDA Approvals, 2002 – June 2010
Hanford Manufacturing ANDA Approvals, 2002 – June 2010
Harmony Labs ANDA Approvals, 2002 – June 2010
Hi-Tech Pharmacal ANDA Approvals, 2002 – June 2010
Hi-Tech Pharmacal: Consolidated Fiscal Year Results, in US$ millions)
Indicus Pharmaceuticals ANDA Approvals, 2002 – June 2010
InvaGen Pharmaceuticals ANDA Approvals, 2002 – June 2010
KUDCo ANDA Approvals, 2002 – June 2010
KV Pharmaceuticals / Ethex ANDA Approvals, 2002 – June 2010
KV Pharmaceutical: Financial Results, in US$ millions
KVK-Tech ANDA Approvals, 2002 – June 2010
Luitpold Pharmaceuticals ANDA Approvals, 2002 – June 2010
Lyne Laboratories ANDA Approvals, 2002 – June 2010
Mallinckrodt ANDA Approvals, 20002 – June 2010
Mikart ANDA Approvals, 2002 – June 2010
Neil Laboratories ANDA Approvals, 2002 – June 2010
Nephron Pharmaceuticals ANDA Approvals, 2002 – June 2010
Paddock Laboratories ANDA Approvals, 2002 – June 2010
Pharmaceutical Associates ANDA Approvals, 2002 – June 2010
PharmaForce ANDA Approvals, 2002 – June 2010
Prometheus Laboratories ANDA Approvals, 2002 – June 2010
Roxane Laboratories ANDA Approvals, 2002 – June 2010
RxElite ANDA Approvals, 2002 – June 2010
Silarx Pharmaceuticals ANDA Approvals, 2002 – June 2010
Spear Pharmaceuticals ANDA Approvals, 2002 – June 2010
Stason Pharmaceuticals ANDA Approvals, 2002 – June 2010
Stiefel ANDA Approvals, 2002 – June 2010
SuperGen ANDA Approvals, 2002 – June 2010
SuperGen: Financial Results, in US$ millions
ThePharmaNetwork ANDA Approvals, 2002 – June 2010
Three Rivers ANDA Approvals, 2002 – June 2010
Mutual Pharmaceutical Company ANDA Approvals, 2002 – June 2010
Upsher-Smith Laboratories ANDA Approvals, 2002 – June 2010
VersaPharm ANDA Approvals, 2002 – June 2010
Covenant Pharma ANDA Approvals, 2002 – June 2010
Vista Pharmaceuticals ANDA Approvals, 2002 – June 2010
VistaPharm ANDA Approvals, 2002 – June 2010
X-GEN Pharmaceuticals ANDA Approvals, 2002 – June 2010

Ask Your Question

Partnering in the Global Generics Industry 2010: A guide to companies
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: